249 related articles for article (PubMed ID: 22161865)
1. MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer.
Xu B; Wang N; Wang X; Tong N; Shao N; Tao J; Li P; Niu X; Feng N; Zhang L; Hua L; Wang Z; Chen M
Prostate; 2012 Aug; 72(11):1171-8. PubMed ID: 22161865
[TBL] [Abstract][Full Text] [Related]
2. miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1.
Sun Q; Zhao X; Liu X; Wang Y; Huang J; Jiang B; Chen Q; Yu J
Prostate; 2014 Dec; 74(16):1613-21. PubMed ID: 25214035
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2.
Ma S; Chan YP; Kwan PS; Lee TK; Yan M; Tang KH; Ling MT; Vielkind JR; Guan XY; Chan KW
Cancer Res; 2011 Jan; 71(2):583-92. PubMed ID: 21224345
[TBL] [Abstract][Full Text] [Related]
4. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1.
Xu B; Huang Y; Niu X; Tao T; Jiang L; Tong N; Chen S; Liu N; Zhu W; Chen M
Prostate; 2015 Dec; 75(16):1896-903. PubMed ID: 26306811
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of miR-146a in gastric cancer cases.
Kogo R; Mimori K; Tanaka F; Komune S; Mori M
Clin Cancer Res; 2011 Jul; 17(13):4277-84. PubMed ID: 21632853
[TBL] [Abstract][Full Text] [Related]
6. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
7. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
[TBL] [Abstract][Full Text] [Related]
8. Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis.
Xiao B; Zhu ED; Li N; Lu DS; Li W; Li BS; Zhao YL; Mao XH; Guo G; Yu PW; Zou QM
Oncol Rep; 2012 Feb; 27(2):559-66. PubMed ID: 22020746
[TBL] [Abstract][Full Text] [Related]
9. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
13. microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer.
Hou Z; Yin H; Chen C; Dai X; Li X; Liu B; Fang X
Mol Med Rep; 2012 Sep; 6(3):501-6. PubMed ID: 22711166
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
16. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo.
Xu B; Feng NH; Li PC; Tao J; Wu D; Zhang ZD; Tong N; Wang JF; Song NH; Zhang W; Hua LX; Wu HF
Prostate; 2010 Apr; 70(5):467-72. PubMed ID: 19902466
[TBL] [Abstract][Full Text] [Related]
17. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.
Locke JA; Guns ES; Lubik AA; Adomat HH; Hendy SC; Wood CA; Ettinger SL; Gleave ME; Nelson CC
Cancer Res; 2008 Aug; 68(15):6407-15. PubMed ID: 18676866
[TBL] [Abstract][Full Text] [Related]
18. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55.
You B; Zhang KC
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7660-7670. PubMed ID: 30536308
[TBL] [Abstract][Full Text] [Related]
20. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S
Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
